Skip to content
healthcare.dev

COXANTO

NDC 70512-814, oxaprozin, capsule, from SOLA Pharmaceuticals, LLC.

Product NDC
70512-814
Status
Listed
Labeler
SOLA Pharmaceuticals, LLC
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA217927
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70512-814 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OXAPROZIN300 mg/1

Pharmacologic classes

Anti-Inflammatory Agents, Non-Steroidal [CS]; Cyclooxygenase Inhibitors [MoA]; Nonsteroidal Anti-inflammatory Drug [EPC]

Package NDCNDC-11Package
70512-814-607051208146060 CAPSULE in 1 BOTTLE (70512-814-60)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/918127f0-9f2a-4edf-a2f7-07c01aa52bb5

Use it

Look up 70512-814 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70512-814 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70512-814. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.